Bone density in axial and appendicular skeleton in patients with lactose intolerance: influence of calcium intake and vitamin D status
- PMID: 12805246
- DOI: 10.1080/07315724.2003.10719294
Bone density in axial and appendicular skeleton in patients with lactose intolerance: influence of calcium intake and vitamin D status
Abstract
Background: Lactose intolerance (LI) is a common enzymatic insufficiency, manifesting by poor tolerance of dairy products, leading to low calcium intake and poor calcium absorption from dairy products. These changes might lead to an impairment of bone metabolism [1].
Objectives: To evaluate the impact of LI on quantitative bone parameters in axial and appendicular skeletal sites. To assess the impact of calcium intake from dairy and non-dairy nutritional sources, calcium regulating hormones and bone turnover on quantitative bone parameters in LI patients.
Methods: We evaluated calcium intake and bone status in sixty-six patients with LI, 49 women and 17 men, aged 20 to 78. Bone mass was assessed at the lumbar spine (LS), total hip (TH) and femoral neck (FN) by dual-energy x-ray absorptiometry (DEXA) and at the radius, tibia, phalanx by quantitative ultrasound. Serum calcium, albumin, inorganic phosphate, calcium regulating hormones and markers of bone turnover were evaluated.
Results: Total daily calcium intake was below the recommended by the American Dietetic Association [2] in all study participants (mean 692 mg/day +/- 162). Elevated level of urinary deoxypyridinoline crosslinks (DPD) was observed in 63 (96%) patients and was negatively correlated with total daily calcium intake (r = -0.998, p = 0.025) and with nondairy calcium intake (r = -0.34, p = 0.015). Parathyroid hormone (PTH) level in the upper third of normal range (45-65 ng/L) was observed in 11 (17%) patients. Parathyroid hormone (PTH) was inversely correlated with total calcium intake (r = -0.4, p = 0.001), dairy calcium intake (r = -0.83, p = 0.05), non-dairy calcium intake (r = -0.29, p = 0.043), 25OHD(3) serum level (r = -0.3, p = 0.007) and positively correlated with bone turnover markers (deoxypyridinoline crosslinks [DPD], r = 0.36, p = 0.01 and bone specific alkaline phosphatase [BSAP] r = 0.36, p = 0.01). Decrease in quantitative bone parameters compared to age-matched controls was observed in the axial and in the appendicular skeleton in men and in postmenopausal women: mean z-score for LS -0.87 +/- 0.22 and -1.32 +/- 0.65, p = 0.004 and 0.015, tibia -1.15 +/- 0.53 and -0.44 +/- 0.044, p < 0.001 and 0.27, phalanx -0.98 +/- 0.22 and -0.52 +/- 0.98, p < 0.001. We observed decrease in bone mass in patients with serum PTH in the upper tertile of normal range in the FN (z-score -0.57 +/- 0.6 versus -0.03 +/- 0.9, p = 0.025), TH (-0.51 +/- 0.96 versus 0.04 +/- 0.9, p = 0.05) and radius (-1.84 +/- 0.27 versus -0.07 +/- 1.61, p = 0.025, respectively). z-scores in FN and TH positively correlated with serum 25OHD(3) level (r = 0.31, 0.29; p = 0.014, 0.019). In postmenopausal women serum 25OHD(3) level correlated also with LS z-scores (r = 0.52, p = 0.004); FN and TH z-scores negatively correlated with DPD level (r = -0.51, p = 0.02 and r = -0.55, p = 0.04).
Conclusion: LI state may lead to increased bone turnover and decreased bone mass especially in men and postmenopausal women. Impaired vitamin D status and low calcium intake may be deleterious to bone in this condition.
Similar articles
-
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.J Clin Endocrinol Metab. 2001 Mar;86(3):1212-21. doi: 10.1210/jcem.86.3.7327. J Clin Endocrinol Metab. 2001. PMID: 11238511 Clinical Trial.
-
Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.Calcif Tissue Int. 1999 Jul;65(1):23-8. doi: 10.1007/s002239900652. Calcif Tissue Int. 1999. PMID: 10369729
-
Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.Osteoporos Int. 2016 Jan;27(1):105-13. doi: 10.1007/s00198-015-3219-6. Epub 2015 Jul 2. Osteoporos Int. 2016. PMID: 26134682
-
The Effects of Dairy Product Supplementation on Bone Health Indices in Children Aged 3 to 18 Years: A Meta-Analysis of Randomized Controlled Trials.Adv Nutr. 2023 Sep;14(5):1187-1196. doi: 10.1016/j.advnut.2023.06.010. Epub 2023 Jul 4. Adv Nutr. 2023. PMID: 37414219 Free PMC article. Review.
-
[Lactose intolerance and consumption of milk and milk products].Z Ernahrungswiss. 1997 Dec;36(4):375-93. doi: 10.1007/BF01617834. Z Ernahrungswiss. 1997. PMID: 9467238 Review. German.
Cited by
-
Osteoporosis in children and young adults: a late effect after chemotherapy for bone sarcoma.Clin Orthop Relat Res. 2012 Oct;470(10):2874-85. doi: 10.1007/s11999-012-2448-7. Epub 2012 Jul 18. Clin Orthop Relat Res. 2012. PMID: 22806259 Free PMC article.
-
Lactose Intolerance and Bone Health: The Challenge of Ensuring Adequate Calcium Intake.Nutrients. 2019 Mar 28;11(4):718. doi: 10.3390/nu11040718. Nutrients. 2019. PMID: 30925689 Free PMC article. Review.
-
Lactose-Free Dairy Products: Market Developments, Production, Nutrition and Health Benefits.Nutrients. 2019 Mar 5;11(3):551. doi: 10.3390/nu11030551. Nutrients. 2019. PMID: 30841534 Free PMC article. Review.
-
Nutritional management of lactose intolerance: the importance of diet and food labelling.J Transl Med. 2020 Jun 26;18(1):260. doi: 10.1186/s12967-020-02429-2. J Transl Med. 2020. PMID: 32590986 Free PMC article. Review.
-
Lactose Malabsorption and Presumed Related Disorders: A Review of Current Evidence.Nutrients. 2022 Jan 28;14(3):584. doi: 10.3390/nu14030584. Nutrients. 2022. PMID: 35276940 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous